Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00128518
Status:
COMPLETED
Last Update Posted:
2012-01-02
First Post:
2005-08-09
Brief Title:
IDEAL Study Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
IDEAL Study Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs
Status:
COMPLETED
Status Verified Date:
2011-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The principal scientific objective of the trial is to identify the factors that are associated with differential blood pressure responses between drugs This may allow investigators to produce new hypotheses on the pathophysiology of hypertension and on the mechanisms of drug action
These factors can be of different types
Environmental factors sodium or alcohol intake
Morphological height weight body mass index body surface area
Initial blood pressure
Electrocardiogram ECG parameters of left ventricular hypertrophy
Biological parameters as the activity level of the renin angiotensin aldosterone system
Genetic polymorphisms
These factors can be of different types
Environmental factors sodium or alcohol intake
Morphological height weight body mass index body surface area
Initial blood pressure
Electrocardiogram ECG parameters of left ventricular hypertrophy
Biological parameters as the activity level of the renin angiotensin aldosterone system
Genetic polymorphisms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None